United States Antidepressant Drugs Market Report 2017

July 2017 | 98 pages | ID: U9196546340EN
QYResearch

Abstracts

In this report, the United States Antidepressant Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antidepressant Drugs in these regions, from 2012 to 2022 (forecast).

United States Antidepressant Drugs market competition by top manufacturers/players, with Antidepressant Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Pfizer
• Lundbeck
• Teva Pharmaceutical
• SMA
• Eli Lilly and Company
• Forest Laboratories
• Schering-Plough
• Novartis
• Sanofi

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• MAOIs
• SSRIs
• TCAs
• SNRI
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antidepressant Drugs for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antidepressant Drugs Market Report 2017

1 ANTIDEPRESSANT DRUGS OVERVIEW

1.1 Product Overview and Scope of Antidepressant Drugs
1.2 Classification of Antidepressant Drugs by Product Category
  1.2.1 United States Antidepressant Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antidepressant Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 MAOIs
  1.2.4 SSRIs
  1.2.5 TCAs
  1.2.6 SNRI
  1.2.7 Others
1.3 United States Antidepressant Drugs Market by Application/End Users
  1.3.1 United States Antidepressant Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 United States Antidepressant Drugs Market by Region
  1.4.1 United States Antidepressant Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antidepressant Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Antidepressant Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antidepressant Drugs Status and Prospect (2012-2022)
  1.4.5 New England Antidepressant Drugs Status and Prospect (2012-2022)
  1.4.6 The South Antidepressant Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Antidepressant Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antidepressant Drugs (2012-2022)
  1.5.1 United States Antidepressant Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Antidepressant Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIDEPRESSANT DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antidepressant Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antidepressant Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antidepressant Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Antidepressant Drugs Market Competitive Situation and Trends
  2.4.1 United States Antidepressant Drugs Market Concentration Rate
  2.4.2 United States Antidepressant Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antidepressant Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIDEPRESSANT DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antidepressant Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Antidepressant Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Antidepressant Drugs Price by Region (2012-2017)

4 UNITED STATES ANTIDEPRESSANT DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antidepressant Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antidepressant Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Antidepressant Drugs Price by Type (2012-2017)
4.4 United States Antidepressant Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIDEPRESSANT DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antidepressant Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Antidepressant Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIDEPRESSANT DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antidepressant Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Antidepressant Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Lundbeck
  6.3.2 Antidepressant Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Lundbeck Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Teva Pharmaceutical
  6.4.2 Antidepressant Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Teva Pharmaceutical Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 SMA
  6.5.2 Antidepressant Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 SMA Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Eli Lilly and Company
  6.6.2 Antidepressant Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eli Lilly and Company Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Forest Laboratories
  6.7.2 Antidepressant Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Forest Laboratories Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Schering-Plough
  6.8.2 Antidepressant Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Schering-Plough Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Novartis
  6.9.2 Antidepressant Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sanofi
  6.10.2 Antidepressant Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sanofi Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANTIDEPRESSANT DRUGS MANUFACTURING COST ANALYSIS

7.1 Antidepressant Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antidepressant Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antidepressant Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antidepressant Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIDEPRESSANT DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antidepressant Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antidepressant Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Antidepressant Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Antidepressant Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antidepressant Drugs
Figure United States Antidepressant Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Antidepressant Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure MAOIs Product Picture
Figure SSRIs Product Picture
Figure TCAs Product Picture
Figure SNRI Product Picture
Figure Others Product Picture
Figure United States Antidepressant Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Antidepressant Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure United States Antidepressant Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Antidepressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antidepressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antidepressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antidepressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antidepressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antidepressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antidepressant Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Antidepressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antidepressant Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Antidepressant Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Antidepressant Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antidepressant Drugs Sales Share by Players/Suppliers
Figure 2017 United States Antidepressant Drugs Sales Share by Players/Suppliers
Figure United States Antidepressant Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antidepressant Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antidepressant Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antidepressant Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Antidepressant Drugs Revenue Share by Players/Suppliers
Table United States Market Antidepressant Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Antidepressant Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Antidepressant Drugs Market Share of Top 3 Players/Suppliers
Figure United States Antidepressant Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antidepressant Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antidepressant Drugs Product Category
Table United States Antidepressant Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Antidepressant Drugs Sales Share by Region (2012-2017)
Figure United States Antidepressant Drugs Sales Share by Region (2012-2017)
Figure United States Antidepressant Drugs Sales Market Share by Region in 2016
Table United States Antidepressant Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antidepressant Drugs Revenue Share by Region (2012-2017)
Figure United States Antidepressant Drugs Revenue Market Share by Region (2012-2017)
Figure United States Antidepressant Drugs Revenue Market Share by Region in 2016
Table United States Antidepressant Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Antidepressant Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Antidepressant Drugs Sales Share by Type (2012-2017)
Figure United States Antidepressant Drugs Sales Share by Type (2012-2017)
Figure United States Antidepressant Drugs Sales Market Share by Type in 2016
Table United States Antidepressant Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antidepressant Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antidepressant Drugs by Type (2012-2017)
Figure Revenue Market Share of Antidepressant Drugs by Type in 2016
Table United States Antidepressant Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Antidepressant Drugs Sales Growth Rate by Type (2012-2017)
Table United States Antidepressant Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Antidepressant Drugs Sales Market Share by Application (2012-2017)
Figure United States Antidepressant Drugs Sales Market Share by Application (2012-2017)
Figure United States Antidepressant Drugs Sales Market Share by Application in 2016
Table United States Antidepressant Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Antidepressant Drugs Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure GSK Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure GSK Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Lundbeck Basic Information List
Table Lundbeck Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Lundbeck Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure Lundbeck Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure Lundbeck Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table SMA Basic Information List
Table SMA Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure SMA Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure SMA Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure SMA Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Forest Laboratories Basic Information List
Table Forest Laboratories Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Forest Laboratories Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure Forest Laboratories Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure Forest Laboratories Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Schering-Plough Basic Information List
Table Schering-Plough Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Schering-Plough Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure Schering-Plough Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure Schering-Plough Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure Novartis Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Antidepressant Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Antidepressant Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Antidepressant Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Antidepressant Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidepressant Drugs
Figure Manufacturing Process Analysis of Antidepressant Drugs
Figure Antidepressant Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antidepressant Drugs Major Players/Suppliers in 2016
Table Major Buyers of Antidepressant Drugs
Table Distributors/Traders List
Figure United States Antidepressant Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Antidepressant Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antidepressant Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Antidepressant Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antidepressant Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antidepressant Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Antidepressant Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antidepressant Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antidepressant Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Antidepressant Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Antidepressant Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antidepressant Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antidepressant Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources